Novel Nortriterpenes from Phlomis umbrosa

Area of Science:

• Natural Product Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Phlomis umbrosa rhizomes are a source of bioactive natural products.
• Triterpenoids are a diverse class of organic compounds with various biological activities.
• Spirocyclic triterpenoids with unusual skeletons are of significant interest in medicinal chemistry.

Purpose of the Study:

• To isolate and characterize novel spirocyclic triterpenoids from Phlomis umbrosa.
• To evaluate the cytotoxic activities of the isolated compounds against cancer cell lines.
• To investigate the structure-activity relationships of these compounds.

Main Methods:

• Extraction of Phlomis umbrosa rhizomes using ethanol.
• Structure elucidation using spectroscopic methods: 1D and 2D Nuclear Magnetic Resonance (NMR), High-Resolution Mass Spectrometry (HR-MS).
• X-ray crystallographic analysis for definitive structural confirmation.
• In vitro cytotoxic assays against Hela and L929 carcinoma cell lines.

Main Results:

• Isolation of eight novel 28-noroleanane-derived spirocyclic triterpenoids: phlomisone (1), phlomistetraol A (2), phlomistetraol B (3), phlomistetraol C (4), phlomispentaol (5), phlomishexaol A (6), phlomishexaol B (7), and phlomisin (8).
• Compounds 1-3, 5, and 7 demonstrated positive cytotoxic effects against Hela and L929 cell lines.
• Preliminary structure-activity relationship analysis suggested that oxygenated functions at C-18 and C-21 positions enhance cytotoxic activity.

Conclusions:

• The study successfully identified and characterized eight new spirocyclic triterpenoids from Phlomis umbrosa.
• Several isolated compounds exhibit significant in vitro cytotoxic activity, highlighting their potential as anticancer agents.
• The findings provide insights into the structural features contributing to the bioactivity of these novel triterpenoids.